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Abstract
Background: Acute lower respiratory tract infections (LRTI) are a frequent cause of hospitalization and mortality in
South Africa; however, existing respiratory severity scores may underestimate mortality risk in HIV-infected adults in
resource limited settings. A simple predictive clinical score for low-resource settings could aid healthcare providers
in the management of patients hospitalized with LRTI.
Methods: We analyzed 1,356 LRTI hospitalizations in adults aged ≥18 years enrolled in Severe Acute Respiratory
Illness (SARI) surveillance in three South African hospitals from January 2010 to December 2011. Using demographic
and clinical data at admission, we evaluated potential risk factors for in-hospital mortality. We evaluated three
existing respiratory severity scores, CURB-65, CRB-65, and Classification Tree Analysis (CTA) Score assessing for
discrimination and calibration. We then developed a new respiratory severity score using a multivariable logistic
regression model for in-hospital mortality and assigned points to risk factors based on the coefficients in the
multivariable model. Finally we evaluated the model statistically using bootstrap resampling techniques.
Results: Of the 1,356 patients hospitalized with LRTI, 101 (7.4%) died while hospitalized. The CURB-65, CRB-65, and
CTA scores had poor calibration and demonstrated low discrimination with c-statistics of 0.594, 0.548, and 0.569
respectively. Significant risk factors for in-hospital mortality included age ≥ 45 years (A), confusion on admission (C),
HIV-infection (H), and serum blood urea nitrogen >7 mmol/L (U), which were used to create the seven-point ACHU
clinical predictor score. In-hospital mortality, stratified by ACHU score was: score ≤1, 2.4%, score 2, 6.4%, score 3, 11.
9%, and score ≥ 4, 29.3%. Final models showed good discrimination (c-statistic 0.789) and calibration (chi-square 1.6,
Hosmer-Lemeshow goodness-of-fit p-value = 0.904) and discriminated well in the bootstrap sample (average
optimism of 0.003).
Conclusions: Existing clinical predictive scores underestimated mortality in a low resource setting with a high HIV
burden. The ACHU score incorporates a simple set a risk factors that can accurately stratify patients ≥18 years of
age with LRTI by in-hospital mortality risk. This score can quantify in-hospital mortality risk in an HIV-endemic,
resource-limited setting with limited clinical information and if used to facilitate timely treatment may improve
clinical outcomes.
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Background
Acute lower respiratory tract infections (LRTI) are one
of the most frequent causes of hospitalization in South
Africa with an overall incidence ranging from 325 to
617/100,000 population annually [1]. In South Africa,
HIV-infected individuals have higher rates of
hospitalization and an increased risk of death from LRTI
compared with HIV-uninfected individuals [1]. Many
respiratory severity scores that use clinical and labora-
tory data have been developed to risk stratify and predict
outcomes of patients hospitalized with pneumonia
including the Pneumonia Severity Index (PSI) and
CURB-65 scores [2–5]. Although these scores are used
frequently in clinical practice, including in South Africa,
they were developed and validated among HIV-
uninfected adults in high income settings and may
therefore underestimate mortality risk in HIV-infected
adults in resource-limited settings [6]. Several respira-
tory severity scores have been developed for hospitalized
HIV-infected adults and children [7–9], but they are not
widely used or have not been prospectively validated to
date. Having an accurate predictive respiratory severity
score for low-resource settings could help healthcare
providers and health systems better allocate limited
resources and improve care by identifying patients at
risk for severe outcomes.
We used data from Severe Acute Respiratory Illness
(SARI) surveillance in South Africa, an active, prospect-
ive hospital-based surveillance system, to evaluate exist-
ing respiratory severity scores in a patient population
with high HIV prevalence. We then sought to develop a
novel severity score for LRTI in adults for use in resource-
limited settings, including an assessment of its ability to




The protocol was approved by the Research Ethics
Committees of the University of the Witwatersrand
(reference number M081042). This investigation was
deemed non-research by the U.S. Centers for Disease
Control and Prevention and did not need human sub-
jects review by that institution. Written informed con-
sent was obtained from adults aged ≥18 years upon
enrollment in the SARI surveillance system for the
collection of nasopharyngeal and throat swabs and
blood specimens. All specimens collected from con-
senting patients were part of SARI surveillance or
routine clinical care.
SARI Surveillance
We performed a secondary analysis of data from hospital-
ized adults aged ≥18 years enrolled in SARI surveillance in
South Africa from January 2010 through December 2011.
SARI surveillance in South Africa has been previously
described [10]. SARI was an active, prospective hospital-
based surveillance program for cases of acute LRTI,
defined as a hospitalized case in persons ≥5 years of age
who met a modified 2011 World Health Organization
(WHO) case definition for severe acute respiratory infec-
tion: sudden onset of fever (>38 °C) or reported fever,
cough or sore throat, and shortness of breath or difficulty
breathing with illness onset within 7 days prior to admis-
sion [11]. Surveillance officers review patient admission
logs daily, consent, and enroll eligible cases, perform a
medical chart review and patient interview and collect
respiratory specimens for bacterial and viral pathogen
testing. We included patients from three study sites in two
provinces: (1) Tshepong Hospital, a public, semi-rural 300
bed hospital in Klerksdorp, North West Province; (2)
Chris Hani Baragwanath Academic Hospital (CHBAH), a
public, urban 3,200 bed hospital in Soweto, Gauteng Prov-
ince; and (3) Selby Hospital, a private, urban 642 bed
hospital in Johannesburg, Gauteng Province, that receives
referrals of stable patients from area hospitals, includ-
ing CHBAH. All hospitals have general medical wards
and intensive care units (ICUs) with the capability for
mechanical ventilation.
Study population and data collection
The primary outcome was in-hospital mortality among
patients ≥18 years of age hospitalized with LRTI. From
January 2010 to December 2011, there were 1,988 SARI
patients enrolled at Selby hospital, 991 SARI patients
enrolled at CHBAH, and 76 SARI patients enrolled from
Tshepong hospital. The study was powered for 10 de-
grees of freedom, which required 100 occurrences of
death. In order to reach this sample size, we randomly
sampled 60% of the SARI patients from Selby, CHBAH,
and Tshepong hospital irrespective of outcome for chart
review from the 2-year study period. This was estimated
to provide 140 deaths.
We collected the following data for each enrolled
SARI patient: demographics, underlying medical condi-
tions, vital signs, signs and clinical examination findings,
HIV status, and laboratory values including serum blood
urea nitrogen (BUN), creatinine, and sodium. SARI
surveillance records and the clinical laboratory database
were the primary data sources, though investigators also
performed retrospective chart review using a standard-
ized data collection instrument to abstract data on
several variables including mental status, blood pressure,
and oxygen saturation which were not included in
routine SARI data collection. We used the first available
vital signs and laboratory values from the hospital
admission as predictors for those variables. First avail-
able was defined as preferentially using vital signs and
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laboratory values recorded from the initial encounter in
the casualty ward (emergency department); however, if
values were unavailable from the casualty ward, we used
the initial vital signs and laboratory values from the
inpatient ward. Variables with >25% missing values were
excluded from the analysis (Additional file 1).
Assessment of risk factors for in-hospital death
To better understand important mortality predictors in
this population, we evaluated the relationship between
patient clinical characteristics and the primary outcome.
We performed chi-square or Fisher’s exact tests to
compare proportions for binary variables and the
Wilcoxon rank sum test to evaluate distribution differ-
ences between continuous variables. All comparisons
were 2-tailed and p < 0.05 was considered significant. We
calculated unadjusted odds ratios and 95% confidence
intervals (CI) for mortality using logistic regression.
Evaluation of existing respiratory severity scores
We evaluated three existing respiratory severity scores,
CURB-65, CRB-65, and Classification Tree Analysis
(CTA) Score [3, 7], for our study population (Additional
file 2: Table S1). We calculated the respective scores for
each patient and the observed mortality risk by score
category. We then evaluated the predictive accuracy of
the scores by assessing the discrimination and calibra-
tion of each score for mortality in our study population
(Additional file 2: Table S2) [3, 7]. Discrimination refers
to the model’s ability to distinguish between individuals
with and without the outcome of interest (in this case
mortality) and was measured using the c-statistic or area
under the receiver operating characteristic (ROC) curve
[12]. Calibration measures the concordance of predicted
and observed outcomes and was assessed visually as well
as by using the Hosmer-Lemeshow goodness of fit test.
[12] For the purposes of evaluating each score, we
excluded individuals who had missing values for any of
the predictor variables included in that severity score.
Development of a new scoring system
To develop a new scoring system, we implemented a risk
factor analysis for mortality by creating a multivariable
logistic regression model using risk factors associated
with mortality as identified in the univariate analysis
with p < 0.2. We evaluated all included variables for
interaction with one another, and then performed man-
ual backward elimination in which non-significant vari-
ables were removed from the model one at a time
starting with the variable with the smallest magnitude of
effect until either all remaining variables had p < 0.05 or
removing an additional variable significantly affected the
model’s Akaike information criterion (AIC). The final
multivariable logistic regression model was used to
create a point-based scoring system in which “point
values” were assigned by rounding the beta coefficient of
each predictor in the model to the nearest integer [9].
Internal validation
We evaluated the predictive accuracy of the new scoring
system by assessing the discrimination and calibration of
the model in our data. Since prediction models generally
perform better on the initially observed population com-
pared to new populations, we assessed this “optimism”
by using standard bootstrap procedures [13]. To assess
the internal validity of our model, bootstrap samples were
drawn with replacement and of the same size as the
original sample. The multivariable model was re-
estimated in 300 bootstrap samples and each model was
evaluated on the new sample and the original data. The
average difference in the c-statistic indicates the optimism
in the initially estimated discrimination [14].
All statistical analyses were performed using SAS
version 9.3 (SAS Institute, Cary, NC).
Results
Study population and risk factors associated with
mortality
From January 2010 to December 2011, there were 3,029
SARI cases including 218 (7.2%) deaths from CHBAH
and Selby Hospital and 71 cases including 5 deaths from
Tshepong Hospital. For our study, we evaluated the re-
cords of 1356 randomly selected SARI patients including
101 (7.4%) who died while hospitalized. Nine hundred
forty-three (69.5%) patients were from Selby Hospital,
374 (27.6%) were from CHBAH, and 39 (2.9%) were
from Tshepong Hospital. 1019/1325 (76.9%) were HIV-
infected. Of the 376 (36.9%) HIV-infected patients with
documented CD4 counts, the median CD4 count was
104 cells/mm3 (IQR 34.5–260.0 cells/mm3). Of the 1008
(98.9%) HIV-infected patients with documentation re-
garding antiretroviral therapy, 217 (21.5%) were known
to be on treatment. 189/1356 (13.9%) of SARI patients
included in this analysis had tuberculosis.
Chest radiography was performed on 843 (62.2%) of
hospitalized LRTI patients. Pulse oximetry was docu-
mented in 745 (54.9%) patients, and 235 (17.3%) patients
had documented receipt of any form of supplemental
oxygen. No patients were admitted to the intensive care
unit or were mechanically ventilated.
Table 1 shows risk factors associated with mortality for
patients hospitalized with LRTI from univariate and
multivariate analyses. Additionally, of the 745 patients
with documented pulse oximetry, those who died had a
lower oxygen saturation (median 92.5% (IQR 88–97%))
compared to those who were discharged (median 95.0%
(IQR 91–97%) p = 0.02). Of the 96 individuals who
received supplemental oxygen and had documented
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pulse oximetry, 49 (51.0%) had hypoxemia with an
oxygen saturation less than 90%. Patients who died
were more likely to have tuberculosis compared to
those who were discharged (23/101 (22.8%) versus
166/1255 (13.2%), p = 0.01). Patients who died were
more likely to have a longer delay between symptom
onset and hospital admission than those who were
discharged (median 5 days, (IQR 4–7) versus median
5 days (IQR 3–6), p = 0.02).
Evaluation of existing severity scores in a high HIV
prevalence setting
Table 2 shows predicted and observed mortality risk
based on the risk classification by CURB-65, CRB-65
and the CTA scores. The majority of our patient
population received the lowest possible score in each of
the existing scoring systems including the majority of
those with in-hospital death. For example, 848
(83.9%) patients were classified as low-risk using
CURB-65, equivalent to a CURB-65 score of 0 or 1
that correlates to a 1.5% predicted risk of 30-day
mortality. However, in our population, we observed
6.4% in-hospital mortality for individuals classified as
low-risk using CURB-65. These existing scores dem-
onstrated low discrimination with c-statistics of 0.594,
0.548, and 0.569 for the CURB-65, CRB-65, and CTA
scores respectively. Each of the scores also demon-
strated poor calibration. In particular for the CURB-
65 and CRB-65 scores, the majority of individuals
were unable to attain the highest possible score
Table 1 Risk factors for inpatient-mortality among adults hospitalized with lower respiratory tract infection, South Africa, 2010–2011
(N = 1356)
Risk factor Cases with available
data (N = 1356)
Died
N = 101, No. (%)
Discharged
N = 1255, No. (%)




Age≥ 45 years† 1356 67 (66.3) 561 (44.7) <0.001 2.4 (1.6–3.7) 2.5 (1.4–4.2)
Male 1356 49 (48.5) 464 (37.0) 0.0214 1.6 (1.1–2.4) 0.8 (0.5–1.3)
Medical condition
HIV 1325 87/98 (88.8) 932/1227 (76.0) 0.0038 2.5 (1.3–4.8) 2.9 (1.2–6.9)
Asthma 1356 2 (2) 82 (6.5) 0.0678 0.3 (0.1–1.2) −
Diabetes 1356 3 (3) 43 (3.4) 1.0 0.9 (0.3–2.8) −
Cardiovascular§ 1356 2 (2) 41 (3.2) 0.77 0.6 (0.1–2.5) −
Emphysema 1356 1 (1) 22 (1.8) 1.0 0.6 (0.1–4.2) −
Cancer 1356 0 (0) 10 (0.8) 1.0 Not applicable −
Other¶ 1356 0 (0) 18 (1.4) 0.39 Not applicable −
Clinical Data




1356 35 (34.7) 200 (15.9) <0.001 2.8 (1.8–4.3) 2.0 (1.2–3.5)
Temperature ≥38 °C 1328 20/99 (20.2) 299 (24.3) 0.355 0.8 (0.4–1.3) −
Respiratory Rate >20
breaths per minute
1333 36/100 (36.0) 462/1233 (37.5) 0.770 0.9 (0.6–1.4) −
Heart Rate ≥115 beats
per minute
1347 50/100 (50.0) 493/1247 (39.5) 0.040 1.5 (1.0–2.3) 1.6 (0.9–2.7)
Hypotension
(Systolic <90 mmHg or
diastolic ≤60 mmHg)
1352 24/101 (23.8) 249/1251 (19.9) 0.353 1.3 (0.8–2.0) −
Serum Sodium <135
mmol/L
1029 54/80 (67.5) 478/949 (50.4) 0.003 2.0 (1.3–3.3) 1.6 (0.9–2.8)
Urea >7 mmol/L 1029 55/80 (68.8) 274/949 (28.9) <0.001 5.4 (3.3–8.9) 4.4 (2.5–7.6)
Serum Creatinine≥
106.08 μmol/L
1028 34/80 (42.5) 190/948 (20.0) <0.001 2.9 (1.8–4.7) −††
*p-value refers to chi-square or Fischer’s exact test for categorical variables and to a Wilcoxon rank sum test for continuous variables
†Age (median, interquartile range, years) Died 45 (35–53) versus Discharged 38 (30–48) p >0.001
§Includes cardiac and cerebrovascular disease
¶Other includes liver disease, renal disease, spinal disorders, obesity, pregnancy, chemotherapy, autoimmune diseases, and seizure disorders
**“Confusion” based on positive documentation in the medical chart. A no or lack of documentation in the medical chart was classified as “not confused”
††Not included in final multivariate analysis because it demonstrated co-linearity with urea
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because they did not meet the respiratory, blood pres-
sure or age criteria of these scores.
Given the younger median age in our patient cohort,
we modified the CURB-65 score to assign one point for
an age ≥ 45 years (henceforth CURB-45), to see if the
predictive accuracy of the score would improve. Forty-
five years of age was selected as the cut off since it was
the median age of the individuals who died. Table 2
shows the predicted and observed risk of mortality
for the CURB-45 score. The modified score demon-
strated improved discrimination compared to CURB-
65 (c-statistic 0.666 versus 0.594). Additionally, the
CURB-45 score had improved calibration compared
to the CURB-65 score.
Development of a new respiratory severity score
Since the existing severity scores underestimated mortal-
ity risk in our population, we developed a multivariable
logistic regression model for in-hospital mortality using
identified risk factors associated with mortality in our
study population. These risk factors included age ≥
45 years, sex, HIV status, heart rate ≥ 115 beats per
minute, the presence of confusion on clinical examin-
ation, hyponatremia, (serum sodium <135 mEq/L),
elevated urea (serum BUN > 7 mmol/L), and receipt of
supplemental oxygen. Serum creatinine and BUN dem-
onstrated co-linearity, so we only evaluated serum BUN
in the final model since it has been applied to other
commonly used severity scores. Using a manual back-
ward elimination method, sex, heart rate, and serum so-
dium were removed from all final models. Although
receipt of supplemental oxygen was significant, the
removal of this variable resulted in a more parsimonious
model without significantly affecting the AIC. Therefore,
the final model included, age (A), confusion (C), HIV
status (H) and serum BUN (U for uremia) which we will
now refer to as the ACHU score.
Points (e.g. rounding of the beta coefficient to the nearest
integer) assigned to each of the risk factors in the final
model are shown in Table 3. An overall score was calcu-
lated for each patient for an episode of LRTI by adding the
points for each identified risk factor. The new severity score
ranged from 0 to 6, and we stratified the score as follows: a
score of ≤1 was assigned a risk classification of low; a score
of 2 was assigned a risk classification of low-intermediate; a
score of 3 was assigned a risk classification of high-
intermediate; and score ≥ 4 was assigned a risk classification
of high (Table 4 and Additional file 2: Table S3). The me-
dian risk classification was low-intermediate. For each risk
classification, the observed risk of mortality and predicted
probability of death from the model is shown in Table 4.
Validation of the ACHU score
We measured the discrimination and calibration to
evaluate the performance of the ACHU score. In the full
dataset, models using the risk classifications showed
Table 2 Predicted and observed risk of mortality based on risk classification by CURB-65, CRB-65, CTA, and CURB-45 severity scores
among hospitalized adults with lower respiratory tract infections, South Africa, 2010–2011
Severity Score Risk Classification Score N Predicted Mortality (%) Observed Mortality (%) (95% Confidence Interval) C-statistic
CURB-65 (N = 1011)
Low risk 0 or 1 848 1.5 6.4 (4.8–8.2) 0.594
Intermediate risk 2 140 9.2 12.7 (7.8–19.6)
High risk ≥3 23 22.0 34.8 (15.3–54.3)
CRB-65 (N = 1332)
Low risk 0 905 1.2 6.5 (5.0–8.3) 0.548
Intermediate risk 1 or 2 427 8.2 9.6 (7.0–12.8)
High risk 3 or 4 0 31.0 0
CTA (N = 1011)
Stage 1 − 815 2.3 6.9 (5.2–8.8) 0.569
Stage 2 − 114 5.8 7.0 (3.1–13.4)
Stage 3 − 25 12.9 36.0 (18.0–57.5)
Stage 4 − 52 22.0 7.7 (2.1–18.5)
Stage 5 − 5 40.5 60.0 (14.7–94.7)
CURB-45 (N = 1011)
Low risk 0 or 1 751 − 4.9 (3.5–6.7) 0.666
Intermediate risk 2 204 − 12.8 (8.5–18.1)
High risk ≥3 56 − 21.3 (18.8–44.1)
Legend: The CURB-65 and CRB-65 scores predict 30-day mortality risk. The Classification Tree Analysis predicts inpatient mortality risk for HIV-infected patients
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good discrimination (c-statistic 0.789) and calibration
(chi-square 1.6, Hosmer-Lemeshow goodness-of-fit p-
value = 0.904). To assess the internal validity of our
model, we used bootstrapping techniques to estimate
the optimism in our measurement of model discrimin-
ation. From 300 bootstrap samples, the c-statistic ranged
from 0.764 to 0.792 with an estimated average optimism
of 0.003, which indicates that the model discriminates
well when applied to the bootstrapped sample.
Discussion
South African adults hospitalized with LRTI had a high
HIV prevalence and an in-hospital mortality rate of
7.4%. Existing and modified respiratory severity scores
were poor predictors of mortality and underestimated
in-hospital mortality in our population. We developed
and validated a novel clinical prediction score which
uses a simple and commonly available set of clinical fac-
tors and laboratory tests to discriminate between adults
with varying in-hospital mortality risk from LRTI. A
combination of four factors (age ≥ 45 years, confusion on
clinical exam, HIV-infection and BUN >7 mmol/L) in a
scoring model provide good discrimination and calibra-
tion for predicting in-hospital mortality in adults with
LRTI and could be used by clinicians in resource-limited
settings with high HIV prevalence to identify pneumonia
patients with elevated risk of death.
This simplified score combines elements of existing
pneumonia severity scores and has the ability to be
applied to HIV-infected and HIV-uninfected individuals.
We believe that our use of existing surveillance data
from three South African hospitals accurately reflects
the variability of “real world” clinical information avail-
able to clinical staff caring for patients hospitalized with
LRTI. Some factors included in other scores were not
appropriate for our novel score. For example, chest X-
rays were only performed on ~60% of individuals. In
addition, while there was a significant difference between
receipt of supplemental oxygen among deaths and dis-
charges, we found that among those with a documented
oxygen saturation, receipt of supplemental oxygen corre-
lated poorly with documented hypoxemia thus limiting
its reliability as a surrogate marker for hypoxemia.
Our in-hospital mortality rate of 7.4% likely reflects
the high burden of HIV and the high frequency of pul-
monary tuberculosis in our study population—a subset
of LRTI cases identified in South Africa’s SARI surveil-
lance system. Our population appears to be similar to
the overall population of LRTI cases in the SARI surveil-
lance system, which reported an overall case-fatality
ratio of 7.2% [1]. Additionally, the prevalence of HIV
(76.8%) and median age of death among the subgroup in
our analysis was comparable to those in the overall SARI
population [1]. In South Africa, HIV prevalence was
estimated to be 17% in individuals 15–49 years of age in
2012; [15] however, our findings illustrate the high bur-
den of co-existing HIV among patients hospitalized with
LRTI in South Africa. This problem has been previously
described, and the incidence of LRTI hospitalizations for
HIV-infected individuals has been shown to be higher
than what has been described from low HIV-prevalence
middle income countries such as Bangladesh (prevalence
rate estimate from 2013: 0.1%) and other high HIV-
prevalence African countries such as Kenya (prevalence
rate estimate from 2013: 6.0%) [1].
Existing severity scores such as CURB-65 performed
poorly in our study population because they underesti-
mated the risk of death. One of the main limitations of
Table 3 Risk factors for inpatient mortality from the final multivariable model for adults hospitalized with LRTI with ACHU
(age, confusion, HIV, urea) respiratory severity score, South Africa, 2010–2011
Risk factor Adjusted Odds Ratio (95% Confidence Interval) p-value Beta (unexponentiated regression coefficient) Scorea
Age≥ 45 2.3 (1.4–3.9) 0.001 0.85 1
Confusion 9.3 (3.8–22.4) <0.001 2.23 2
HIV-infected 4.2 (1.8–10.1) 0.001 1.44 1
Urea > 7 mmol/L 4.6 (2.7–7.8) <0.001 1.53 2
aThe point value assigned for the score was determined by rounding the beta coefficient to the nearest integer
Table 4 Predicted and observed risk of mortality based on risk classification using the ACHU (Age, confusion, HIV, urea) respiratory
severity score among hospitalized adults with lower respiratory tract infections, South Africa, 2010–2011
ACHU Risk Classificationa Score N Predicted Mortality (%) Observed Mortality (%) (95% Confidence Interval) C-statistic
Low ≤1 570 2.4 2.1 (0.1–3.7) 0.769
Low-intermediate 2 110 6.4 6.4 (2.6–12.7)
High-intermediate 3 230 11.9 14.4 (10.1–19.6)
High ≥4 101 29.3 25.7 (17.6–35.4)
aACHU respiratory severity score risk classification categories are based on the number of points an individual patient has based on the presence or absence of
risk factors associated with in-hospital mortality from our population. The ACHU scores range from 0 to 6
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these severity scores is that they excluded HIV-infected
individuals [3]. However, we also found that Arozullah’s
CTA score, which had been validated in an HIV-infected
population also had poor discrimination and calibration
and generally underestimated mortality in our study
population [7]. Our study population was generally
unable to attain higher risk classifications in these scores
because they did not meet that age threshold (CURB-65
and CRB-65) or the blood pressure or respiratory rate
thresholds (CURB-65, CRB-65, and CTA). We were
unable to evaluate other existing severity scores such as
PSI, PIRO, and SMART-COP because required labora-
tory and clinical findings were not commonly gathered
in our setting; thus, a new score was needed for use with
commonly available data [2, 4, 5]. However, some of
these scores would also be inappropriate for resource
limited-settings, such as ours in which availability of
intensive care units and mechanical ventilator may not
be comparable to high income country settings. We did
find improved discrimination when we modified the
CURB-65 score to have an age cut-off of 45 years of age;
however, it is still based on a predictive model that
excluded HIV-infected individuals.
A clinical predictive score from Uganda for 30-day
mortality in HIV-infected adults was recently developed.
Their study population of 835 patients was similar to
ours in terms of HIV status, young age, low antiretro-
viral coverage, and high frequency of pulmonary tuber-
culosis [8]. Koss et al. identified four clinical predictors
(heart rate above 120 beats/min, respiratory rate above
30 breaths/min, oxygen saturation below 90%, and CD4
cell count below 50 cells/mm3), which were predictive of
increased risk of 30-day mortality [8]. The value of these
predictors have been identified before in other severity
scores in adults and children [2, 3, 7, 9]. We were unable
to evaluate the predictive accuracy of their score on our
study population because we had CD4 cell count infor-
mation or oxygen saturation values recorded for only a
limited subset of our study population. Some of these
criteria such as measurement of oxygen saturation may
not be widely available in resource-limited settings,
which would limit the ability to use their score appropri-
ately. Unlike in their study, we did not find heart rate or
respiratory rate to be predictive of increased risk of
mortality. This differs from other studies which have
identified these as risk factors particularly respiratory rate
[3, 7, 9]. Finally, Koss et al. found a 30-day mortality rate
of 18.2% among patients hospitalized with pneumonia in a
similar patient population of Ugandan adults [8]. The
higher mortality rate found in Koss et al. may be attribut-
able to differences in quality of care and resources in
South African hospitals compared to Ugandan hospitals
as well as to patients who died after hospital dischar-
ged—a period we did not measure in our study.
Our results are subject to several limitations. First, our
mortality outcome was limited to in-hospital mortality
since SARI surveillance does not prospectively follow
patients after hospital discharge; therefore, unlike with
other severity scores such as CURB-65, which predict
30-day mortality risk, we were unable to evaluate our
score’s predictive accuracy for deaths that occur in the
post-discharge period. Second, many patients were miss-
ing data on various risk factors such as oxygen satur-
ation or routine laboratory tests, which have been shown
to be mortality risk factors in other severity scores, and
were therefore unable to account for them in our model.
While this is a limitation, our score was developed in a
“real world” clinical setting and is therefore useful for
settings in which clinical data such as oxygen saturation
or specialized laboratory tests are not routinely available.
Finally, since data on CD4 count and antiretroviral ther-
apy were unavailable on the majority of HIV-infected pa-
tients, we were unable to evaluate for differences in
severity of HIV status.
Conclusion
Our ACHU score incorporates a simple set of predictor
variables that predict the probability of in-hospital mor-
tality in adults hospitalized with LRTI in a middle in-
come country-setting with a high prevalence of HIV.
The ability to quantify the risk of in-hospital mortality in
a resource-limited setting with limited clinical informa-
tion may improve the clinical outcomes of a vulnerable
population by better informing triage decisions on
admission. With further validation in other populations,
this new respiratory severity score may provide middle
income countries with a high HIV-prevalence with a tool
to more effectively manage LRTI and to design clinical
and public health interventions to reduce mortality
based on the severity of LRTI in hospitalized adults.
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